CAMBRIDGE, MA

WHITEHEAD INSTITUTE FOR BIO-MEDICAL RESEARCH

Grant: $47,210 - National Institutes of Health - Jun. 18, 2009

Are you satisfied with this award? or

No votes have been cast for this award yet

Join the conversation: Post a comment about this award


Award Description: Herpesvirues are a significant cause of disease in the human population. Following initial acute infection, herpesvirueses establish latency and the viral DNA is maintained in cells. Murine gammaherpesvirus-68 (MHV-68) is used as a model to study the human gammaherpesvirues, Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus, as MHV-68 shares homology with and demonstrates similar immune responses to these infections. In this proposal we aim to examine a highly conserved viral enzyme, the MHV-68 ORF64 ubiquitin-specific protease (USP). We have generated mutant viruses with which to conduct these studies and have implemented assays to examine changes in viral and cellular gene expression and to quantitate viral load, infectious viral titer, the establishment of latency, reactivation, and immune responses following infection. Additionally, we have proposed a systematic proteomics approach to determine the substrate and interacting partners of the USP. Mutation of the USP in MHV-68 and other herepesvirues leads to a decrease in disease pathology; therefore, we hypothesize that this protease is essential in modulating virus-host interactions, perhaps playing a role in altering the cell cycle or immune responses to the virus. We additionally propose to analyze the contribution of the CD8 T cell response in controlling MHV-68 acute replication and establishment of latency. CD8 T cells may undergo affinity maturation following viral infection; therefore, we propose to examine changes in T cell receptor (TCR) affinity for specific MHV-68 epitopes. Toward this end, we have discovered 19 novel MHV-68 MHC class I epitopes. We will examine the importance of these epitopes by generating virus mutants in which the epitopes are unable to be presented by MHC class I molecules. Generation of MHV-68 CD8 TCR transgenic mouse lines will also help elucidate the function of the cytotoxic T lymphocyte response in controlling viral replication. Relevance: Elucidating the function of the highly conserved herpesviral USP is important in undertanding the pathogenicity of MHV-68. Long-term control of viral infection and the development of a vaccine requires proper activation of the CD8 T cell response to class I MHC epitopes.

Project Description: As Defined in the Awards Description field.

Jobs Summary: Retained Postdoc : stipend to a postdoctoral fellow. (Total jobs reported: 1)

Project Status: Less Than 50% Completed

This award's data was last updated on Jun. 18, 2009. Help expand these official descriptions using the wiki below.


Funds Recipient

WHITEHEAD INSTITUTE FOR BIO-MEDICAL RESEARCH
CAMBRIDGE, MA 02142
See more awards to this recipient

Place of Performance

9 Cambridge Center
Cambridge, MA 02142
See more awards in this zip code



Wiki Description

No comments have been added for this project.

Edit the Wiki Description (editing policy)


Post a comment